Spray chemotherapy for colon cancer spread in the belly
Part of Cancer, Digestive system clinical trials.
This trial tests a new way to give chemotherapy by spraying it into the belly during a minimally invasive surgery. It is for people whose colon or rectal cancer has spread inside the belly (peritoneal metastasis) but not to other organs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have colon or rectal cancer that has spread to the lining of your belly (peritoneal metastasis), but not to other organs.
- You are between 18 and 75 years old.
- You are well enough to be up and about (ECOG score 0, 1, or 2).
- Your blood cell counts and kidney/liver function are within safe limits.
- You have not had other cancers, serious infections, or major belly surgery that would interfere.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to give chemotherapy directly into the belly as a fine mist (called PIPAC) for people whose cancer has spread there. The goal is to see if it’s safe and helps shrink or control the cancer.
This trial compares standard chemotherapy alone to standard chemotherapy plus a special spray of chemotherapy during a short surgery (PIPAC) for colon cancer that has spread to the lining of the belly (the peritoneum) and cannot be removed with surgery. The goal is to see if adding the spray helps shrink or control the cancer better.
This Phase 2 study tests whether spraying chemotherapy into the abdomen (through a small procedure) after colon cancer surgery can lower the chance the cancer comes back. It is meant for people with high-risk tumor features but who have had surgery and have no proven relapse yet.
This trial tests a new way to give chemotherapy – as a fine mist sprayed directly into the belly during a short laparoscopy (keyhole surgery). It is for people whose stomach, pancreas, or colon cancer has spread to the lining of the belly, and who haven't had much chemotherapy before.
This trial tests a new way to deliver chemotherapy directly into the abdomen as a pressurized spray, using a drug called mitomycin. It is for people with appendix or colorectal cancer that has spread to the lining of the abdomen and cannot be removed by surgery.
This trial tests a new way to deliver chemotherapy directly into the abdomen (called PIPAC) for people with cancer spread to the lining of the belly. It uses the drug mitomycin and is for patients who cannot have standard surgery or heated chemotherapy.
Hear when a new Peritoneal Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.